DIL Ltd

DIL Limited is a holding company. The Company is engaged in the business of manufacturing and selling of chemicals primarily bulk drugs and enzymes, renting property, entertainment and utilization of surplus funds for its treasury operations.

Pros:
Company is expected to give good quarter
Company has good consistent profit growth of 52.84% over 5 years
Cons:
Company has a low return on equity of 5.61% for last 3 years.

Peer Comparison

Pharmaceuticals >> Pharmaceuticals - Indian - Bulk Drugs
Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018
37 42 42 40 38 44 44 64 98 97 80 121
33 38 35 41 38 39 42 50 59 59 54 77
Operating Profit 5 5 8 -0 -0 5 2 13 39 38 26 44
OPM % 12% 11% 18% -1% -1% 12% 4% 21% 40% 39% 32% 37%
Other Income 0 0 0 1 1 0 0 4 0 4 3 9
Interest 1 3 3 3 2 2 3 4 2 4 4 5
Depreciation 2 3 2 3 3 3 3 3 3 4 3 3
Profit before tax 2 -1 3 -5 -4 0 -3 11 34 35 22 46
Tax % 23% -161% 33% -23% 0% 239% -9% 40% 23% 24% 24% 25%
Net Profit 0 -3 1 -6 -4 -2 -4 4 19 18 15 32

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 TTM
43 52 67 68 76 119 117 139 142 155 164 302 397
37 42 57 53 57 88 94 112 126 134 152 209 249
Operating Profit 6 11 10 15 19 31 23 27 16 20 12 93 148
OPM % 14% 20% 15% 22% 25% 26% 20% 20% 11% 13% 7% 31% 37%
Other Income 3 2 4 6 23 14 2 2 0 1 3 9 17
Interest 0 1 3 2 1 4 5 5 4 6 10 14 16
Depreciation 3 4 5 4 4 8 9 10 9 8 10 12 12
Profit before tax 6 7 6 15 36 33 10 14 3 7 -6 76 137
Tax % -41% 7% 28% 22% 23% 19% 36% 24% 67% 61% -49% 28%
Net Profit 9 7 6 12 25 22 4 8 0 -1 -11 36 84
EPS in Rs 9.40 7.21 5.74 11.93 26.63 23.05 3.61 8.17 0.25 0.00 0.00 38.91
Dividend Payout % 13% 33% 59% 30% 23% 31% 124% 29% 249% -51% -5% 2%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:19.14%
5 Years:20.95%
3 Years:28.68%
TTM:109.80%
Compounded Profit Growth
10 Years:17.52%
5 Years:52.84%
3 Years:318.21%
TTM:-1320.75%
Return on Equity
10 Years:6.71%
5 Years:4.55%
3 Years:5.61%
TTM:25.93%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Sep 2018
2 2 2 2 2 2 2 2 2 2 2 2 5
Reserves 71 75 77 85 113 127 125 130 129 128 142 124 166
Borrowings 1 12 18 14 20 37 43 65 71 89 87 173 188
13 24 25 21 38 52 57 63 62 72 80 92 147
Total Liabilities 88 113 123 121 173 218 228 261 264 290 312 392 506
28 40 53 39 46 73 94 87 85 168 172 177 172
CWIP 3 8 4 7 14 13 15 36 65 6 5 4 8
Investments 24 20 18 27 41 18 11 17 18 15 18 12 2
32 46 48 48 72 115 107 120 96 101 116 199 323
Total Assets 88 113 123 121 173 218 228 261 264 290 312 392 506

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
6 10 8 2 -1 39 23 14 15 4 2 59
-8 -19 -13 2 -7 -50 -20 -25 -18 -13 7 -101
0 13 4 -5 16 7 -8 13 1 10 -12 89
Net Cash Flow -1 3 -0 -1 8 -4 -4 2 -2 1 -4 47

Ratios Consolidated / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
ROCE % 9% 10% 10% 17% 19% 18% 9% 10% 4% 6% 2% 33%
Debtor Days 44 98 76 64 81 72 79 106 91 101 99 83
Inventory Turnover 5 7 9 9 8 7 5 6 6 6 5 7

Recent Announcements

View all announcements

Annual Reports

Credit Ratings